Fangming Lin, MD, PhD

Board Certifications: 
Pediatrics, Pediatric Nephrology
Accepting New Patients
Treats Children
Profile Hero

Overview

Areas of Expertise / Conditions Treated

Proteinuria, Peritoneal Dialysis, Nephrotic Syndrome, Kidney Transplantation, Kidney Stones, Hypertension, Hemolytic Uremic Syndrome, Hemodialysis, Hematuria, Glomerulonephritis

Academic Appointments

  • Associate Professor of Pediatrics

Administrative Titles

  • Chief, Division of Pediatric Nephrology

Dr. Fangming Lin joined CUMC in June 2011 as the Division Director of Pediatric Nephrology after 10 years of serving University of Texas Southwestern Medical Center at Dallas. She received her MD degree from Fujian Medical University in China and her PhD degree in Pharmacology at New York Medical College. Dr. Lin underwent pediatric residency training at New York University Medical Center and pediatric nephrology fellowship training at Seattle Children’s Hospital of the University of Washington.

As a physician scientist, Dr. Lin has a strong interest in both patient care and science and discovery. She is passionate and experienced in treating children with congenital kidney conditions as well as acquired kidney diseases. Her laboratory research focuses on the understanding and better treatment for acute and chronic kidney disease. She is the first recipient of the Norman Siegel Pediatric Research Grant Award jointly issued by the American Society of Nephrology (ASN) and the American Society of Pediatric Nephrology (ASPN) in 2006 - a humbling selection of which she is proud. Dr. Lin has also served on several committees at the national and international levels.

Email: fl2300@cumc.columbia.edu

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Morgan Stanley Children's Hospital

Gender

  • Female

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-5825

Location(s)

CUMC/NewYork-Presbyterian Morgan Stanley Children's Hospital
3959 Broadway
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Access (Exchange)
  • EPO
  • Gatekeeper (Exchange)
  • HMO
  • Medicare Managed Care
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

TRICARE

  • TRICARE

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Fujian Medical University (China)
  • Internship: New York University Medical Center
  • Residency: New York University Medical Center
  • Fellowship: Seattle Children's Hospital

Board Certifications

  • Pediatrics
  • Pediatric Nephrology
NY Top Doctor

Research

Our laboratory studies kidney injury and repair using a variety of mouse models. We are currently focusing on the function and molecular regulation of epithelial autophagy. We have shown that following urinary tract obstruction or ischemic injury to the kidney, autophagy is activated in a regulated and dynamic fashion for renal tubular survival and repair. A stress-responsive transcription factor FoxO3 plays an important role in regulating the stress response during the acute injury and the progression to chronic kidney disease. Our goal is to use the knowledge learned from animal studies to help design methods that integrate modulation of autophagy into prevention and treatment for human kidney disease.

Grants

GENERATION OF NEW MOUSE MODELS OF LOW NEPHRON NUMBERS TO UNDERSTAND PATHOGENESIS OF AKI AND CKD IN HUMANS BORN PRETERM (Federal Gov)

Feb 15 2019 - November 30 2022

GENERATION OF NEW MOUSE MODELS OF LOW NEPHRON NUMBERS TO UNDERSTAND PATHOGENESIS OF AKIAND CKD IN HUMANS BORN PRETERM (Federal Gov)

Feb 15 2019 - Nov 30 2022

ROLE OF AUTOPHAGY IN MALADAPTIVE RENAL REPAIR FOLLOWING ACUTE KIDNEY INJURY (Federal Gov)

Sep 21 2016 - Aug 31 2019

PSDP FELLOWSHIP (Federal Gov)

Jul 1 2018 - Jun 30 2019

ADVANCING CLINICAL RESEARCH IN PRIMARY GLOMERULAR DISEASES (Federal Gov)

Sep 16 2013 - May 31 2019

STEM CELL THERAPY FOR ACUTE KIDNEY INJURY (Federal Gov)

Jun 1 2011 - Jul 31 2015

ROLE OF AUTOPHAGY IN KIDNEY TUBULAR ATROPHY (Private)

Jun 1 2011 - May 31 2014